A. V. Digtyar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. V. Digtyar has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Iu.V. Olefir
1 shared publication- Natalia V. Pozdniakova
Blokhin National Medical Research Center of Oncology, Ministry of Health of the Russian Federation, Kashirskoe Shosse 24, 115522 Moscow, Russia
1 shared publication - Nataliya B. Feldman
Sechenov First Moscow State Medical University (Sechenov University), 119991, Moscow, Russia
1 shared publication S. E. Severin
Sechenov Moscow Medical Academy
1 shared publication- Sergey V. Lutsenko
Department of Biotechnology, I.M. Sechenov First Moscow State Medical University, 119991 Moscow, Russia
1 shared publication Ye.M. Richikhina
1 shared publication
Latest Publications
- Open Access
- 1 January 2016
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in International Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований)
- Vol. 2 (№ 6 2016)
GROUNDS AND AIMS OF ORPHAN MEDICINE DESIGNATION – WORLD’S ADAPTATION AND THE REGULATORY ENVIRONMENT IN THE RUSSIAN FEDERATION.
- 1 January 2016
- Published by Euroasian Scientific and Industrial Chamber, Ltd. in International Journal of Applied and Fundamental Research (Международный журнал прикладных и фундаментальных исследований)
- Vol. 2 (№ 6 2016)
Open AccessGROUNDS AND AIMS OF ORPHAN MEDICINE DESIGNATION – WORLD’S ADAPTATION AND THE REGULATORY ENVIRONMENT IN THE RUSSIAN FEDERATION.
- 1 March 2007
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 72 (3) , 235-246
Endostatin: Current concepts about its biological role and mechanisms of action
Endogenous inhibitors of angiogenesis are proved to be a major factor preventing the emergence of clinically manifested stages of human cancer. The protein endostatin, a 20-kD proteolytic fragment of...
- 1 March 2007
- Published by Pleiades Publishing Ltd in Biochemistry (Moscow)
- Vol. 72 (3) , 235-246
Endostatin: Current concepts about its biological role and mechanisms of action
Endogenous inhibitors of angiogenesis are proved to be a major factor preventing the emergence of clinically manifested stages of human cancer. The protein endostatin, a 20-kD proteolytic fragment of...